Page last updated: 2024-10-17

bupropion and ADDH

bupropion has been researched along with ADDH in 95 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Research Excerpts

ExcerptRelevanceReference
"Bupropion may be a useful addition to available treatments for ADDH."9.08Bupropion hydrochloride in attention deficit disorder with hyperactivity. ( Ascher, J; Casat, CD; Conners, CK; Gualtieri, CT; Khayrallah, M; Reader, M; Reiss, A; Weller, E; Weller, RA, 1996)
"These naturalistic data suggest that bupropion is well tolerated and may be an effective medication for the treatment of substance abusing adolescents with comorbid mood disorders and ADHD."7.73Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders. ( Biederman, J; Daly, J; Prince, JB; Solhkhah, R; Van Patten, SL; Wilens, TE, 2005)
"Bupropion was associated with reductions in ratings of mania and depression."6.71An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder. ( Biederman, J; Brown, S; Doyle, R; Girard, K; Goldman, S; Hammerness, P; Prince, JB; Spencer, T; Van Patten, SL; Wilens, TE, 2003)
"Eleven boys and eight girls aged 11 to 17 years old were prescribed bupropion SR monotherapy for attention-deficit/hyperactivity disorder (n = 16) and/or depressive disorders (n = 16)."5.11Steady-state pharmacokinetics of bupropion SR in juvenile patients. ( Axelson, DA; Birmaher, B; Brent, DA; Daviss, WB; Gilchrist, R; Nuss, S; Perel, JM; Rudolph, GR, 2005)
"Bupropion SR may be effective and well-tolerated in adolescents with comorbid ADHD and depressive disorders."5.09Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression. ( Bentivoglio, P; Bostic, JQ; Brown, KM; Daviss, WB; Racusin, R; Wiley, L, 2001)
"Bupropion may be a useful addition to available treatments for ADDH."5.08Bupropion hydrochloride in attention deficit disorder with hyperactivity. ( Ascher, J; Casat, CD; Conners, CK; Gualtieri, CT; Khayrallah, M; Reader, M; Reiss, A; Weller, E; Weller, RA, 1996)
"Using the keywords bupropion or Wellbutrin or Zyban or Elontril and attention deficit hyperactivity disorder or ADHD or ADDH, a preliminary search on the PubMed and Ovid databases yielded 25,455 articles published in English between January 1, 1988 and May 1, 2016."4.95A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. ( Ng, QX, 2017)
" Exposure to bupropion during pregnancy (OR = 3."3.76Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring. ( Figueroa, R, 2010)
"These naturalistic data suggest that bupropion is well tolerated and may be an effective medication for the treatment of substance abusing adolescents with comorbid mood disorders and ADHD."3.73Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders. ( Biederman, J; Daly, J; Prince, JB; Solhkhah, R; Van Patten, SL; Wilens, TE, 2005)
"Headache was observed more frequently in the methylphenidate group."2.77Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study. ( Akhondzadeh, S; Ashrafi, M; Jafarinia, M; Khajavi, D; Modabbernia, A; Mohammadi, MR; Tabrizi, M; Yadegari, N, 2012)
"Bupropion was associated with reductions in ratings of mania and depression."2.71An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder. ( Biederman, J; Brown, S; Doyle, R; Girard, K; Goldman, S; Hammerness, P; Prince, JB; Spencer, T; Van Patten, SL; Wilens, TE, 2003)
"Bupropion XL was safe and well tolerated, with no serious or unexpected adverse events and a low rate of drug-related study discontinuation (5%)."2.71Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. ( Connor, DF; Haight, BR; Hampton, KD; Horrigan, JP; Hudziak, JJ; Modell, JG; Richard, NE; Rosenthal, NE; Wilens, TE, 2005)
"Bupropion treatment was associated with a significant change in ADHD symptoms at the week-6 endpoint (42% reduction), which exceeded the effects of placebo (24% reduction)."2.70A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. ( Biederman, J; Comeau, S; Doyle, R; Girard, K; Monuteaux, MC; Parekh, A; Polisner, D; Prince, J; Solhkhah, R; Spencer, TJ; Wilens, TE, 2001)
"Methylphenidate was titrated over 1 week to a maximum dose of 0."2.70Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults. ( Arndt, S; Bever-Stille, KA; Gaffney, GR; Holman, TL; Kuperman, S; Lund, BC; Moser, DJ; Paulsen, JS; Perry, PJ, 2001)
"Methylphenidate was titrated to the maximum effective dose of 0."2.68Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. ( Allen, AJ; Arndt, SV; Barrickman, LL; Herrmann, KJ; Kuperman, S; Perry, PJ; Schumacher, E, 1995)
"Bupropion, an NDRI has a novel effect on ADHD as the molecule exerts its effects by modulating the reward-pleasure mesolimbic dopaminergic system and at the same time regulates the elevating mood dimension of the noradrenergic neurotransmission."2.61The Novelty of Bupropion As a Dopaminergic Antidepressant for the Treatment of Adult Attention Deficit Hyperactive Disorder. ( Adam, RL; Das, S; Deang, KT; Hatta, MH; Hatta, NH; Sidi, H; Wee, KW; Zakaria, H, 2019)
" All studies evaluated a long-acting version of bupropion, with the dosage ranging from 150 mg up to 450 mg daily."2.55Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. ( Bekkering, GE; Kramers, C; Van den Noortgate, W; Verbeeck, W, 2017)
"Methylphenidate displays a high degree of effectiveness and safety in the treatment of adults at doses of around 1 mg/kg/day."2.48[Diagnosis and treatment of attention deficit hyperactivity disorder in adults]. ( Bosch, R; Casas, M; Chalita, PJ; Palomar, G; Prats, L; Ramos-Quiroga, JA; Vidal, R, 2012)
"Only treatment with bupropion seems to have a medium-range effect size, but this is less than that of stimulant medications."2.45Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review. ( Bekkering, GE; Tuinier, S; Verbeeck, W, 2009)
"Commonly co-occurring psychiatric disorders are disruptive behavior disorder, anxiety, depression, bipolar disorder and substance use disorders."2.44Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder. ( Dewan, M; Faraone, SV; Kunwar, A, 2007)
" This review focuses on the tolerability, occurrence of adverse events, precautions required to prevent severe adverse events, and essential pharmacological interaction in the treatment of ADHD symptoms by non-stimulants."2.43The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder. ( Banaschewski, T; Heise, CA; Himpel, S; Rothenberger, A, 2005)
"Clonidine is a good option for managing core behavioral symptoms, especially hyperactivity and impulsivity."2.43Advances in alternative pharmacotherapy of ADHD. ( Pityaratstian, N, 2005)
"When treating adults with ADHD and substance abuse, clinicians should assess the relative severity of the substance abuse, the symptoms of ADHD, and any other comorbid disorders."2.42Impact of ADHD and its treatment on substance abuse in adults. ( Wilens, TE, 2004)
" Methylphenidate and amphetamine-based stimulants are now available in longer-acting, once-daily and shorter-acting divided dosing schedules."2.42Pharmacological management of attention-deficit hyperactivity disorder. ( Reeves, G; Schweitzer, J, 2004)
"Bupropion is a relatively new monocyclic antidepressant whose mechanism of action remains unknown."2.41Bupropion overdose in an adolescent. ( Ayers, S; Tobias, JD, 2001)
" Since psychostimulant treatment often requires frequent dosing and may be associated with unacceptable side effects and risks, other classes of medication have been studied as possible treatment alternatives."2.40Psychopharmacology of ADHD: children and adolescents. ( Dogin, JW; Findling, RL, 1998)
"Although there is no pharmacological treatment for autism spectrum disorder (ASD) itself, behavioral and pharmacological therapies have been used to address its symptoms and common comorbidities."1.62Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database. ( Avillach, P; Feroe, AG; Greenspun, P; Gutiérrez-Sacristán, A; Kohane, IS; Mousavi, S; Surati, R; Uppal, N, 2021)
"Bupropion is an antidepressant drug that is known to aid smoking cessation, although little experimental evidence exists about its actions on active avoidance learning tasks."1.43Differential effects of bupropion on acquisition and performance of an active avoidance task in male mice. ( Carrasco, MC; Gómez, MC; Redolat, R, 2016)
"To estimate the rate of new-onset seizure in ADHD patients in relation to ADHD pharmacotherapy."1.35The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database. ( Holdridge, KC; Hornbuckle, K; Johannes, CB; McAfee, AT; Walker, AM, 2008)
" The active metabolite hydroxybupropion probably has key pharmacodynamic effects, given its higher and more sustained levels relative to the other metabolites or to bupropion."1.33Steady-state clinical pharmacokinetics of bupropion extended-release in youths. ( Axelson, DA; Birmaher, B; Brent, DA; Daviss, WB; Melhem, I; Perel, JM; Rudolph, GR, 2006)
"Bupropion SR has been shown to be effective for the treatment of nicotine dependence in adults."1.32Bupropion SR in adolescents with comorbid ADHD and nicotine dependence: a pilot study. ( Brady, KT; Upadhyaya, HP; Wang, W, 2004)
"Because in many patients with Tourette's syndrome (TS) the ADHD symptoms are the major source of disability, alternative nonstimulant treatments are needed."1.29Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome. ( Biederman, J; Spencer, T; Steingard, R; Wilens, T, 1993)

Research

Studies (95)

TimeframeStudies, this research(%)All Research%
pre-19905 (5.26)18.7374
1990's16 (16.84)18.2507
2000's49 (51.58)29.6817
2010's21 (22.11)24.3611
2020's4 (4.21)2.80

Authors

AuthorsStudies
Elliott, J1
Johnston, A1
Husereau, D1
Kelly, SE1
Eagles, C1
Charach, A1
Hsieh, SC1
Bai, Z1
Hossain, A1
Skidmore, B1
Tsakonas, E1
Chojecki, D1
Mamdani, M1
Wells, GA1
Cândido, RCF1
Menezes de Padua, CA1
Golder, S1
Junqueira, DR1
Feroe, AG1
Uppal, N1
Gutiérrez-Sacristán, A1
Mousavi, S1
Greenspun, P1
Surati, R1
Kohane, IS1
Avillach, P1
Deang, KT1
Sidi, H1
Zakaria, H1
Adam, RL1
Das, S1
Hatta, NH1
Hatta, MH1
Wee, KW1
Verbeeck, W2
Bekkering, GE2
Van den Noortgate, W1
Kramers, C1
Cortese, S2
Adamo, N2
Del Giovane, C2
Mohr-Jensen, C2
Hayes, AJ2
Carucci, S2
Atkinson, LZ2
Tessari, L1
Banaschewski, T3
Coghill, D2
Hollis, C1
Simonoff, E2
Zuddas, A2
Barbui, C2
Purgato, M2
Steinhausen, HC2
Shokraneh, F2
Xia, J2
Cipriani, A2
Su, CC1
Tsai, CY1
Tsai, TH1
Tsai, IJ1
Moriyama, TS1
Polanczyk, GV1
Terzi, FS1
Faria, KM1
Rohde, LA1
Freeman, MP1
Hamedi, M1
Mohammdi, M1
Ghaleiha, A1
Keshavarzi, Z1
Jafarnia, M1
Keramatfar, R1
Alikhani, R1
Ehyaii, A1
Akhondzadeh, S2
Stuhec, M1
Munda, B1
Svab, V1
Locatelli, I1
Gómez, MC1
Redolat, R1
Carrasco, MC1
Buoli, M1
Serati, M1
Cahn, W1
Ng, QX1
Bhatti, S1
McAfee, AT1
Holdridge, KC1
Johannes, CB1
Hornbuckle, K1
Walker, AM1
Covey, LS2
Manubay, J1
Jiang, H1
Nortick, M1
Palumbo, D1
Tuinier, S1
Daughton, JM1
Kratochvil, CJ1
Dopheide, JA1
Pliszka, SR2
Faraone, SV5
Glatt, SJ1
Parikh, SV1
LeBlanc, SR1
Ovanessian, MM1
Figueroa, R1
Diamond, A1
Ondo, WG1
Santosh, PJ1
Sattar, S1
Canagaratnam, M1
Maneeton, N1
Maneeton, B1
Srisurapanont, M1
Martin, SD1
Ramos-Quiroga, JA1
Chalita, PJ1
Vidal, R1
Bosch, R1
Palomar, G1
Prats, L1
Casas, M1
Jafarinia, M1
Mohammadi, MR1
Modabbernia, A1
Ashrafi, M1
Khajavi, D1
Tabrizi, M1
Yadegari, N1
Kornfield, R1
Watson, S1
Higashi, AS1
Conti, RM1
Dusetzina, SB1
Garfield, CF1
Dorsey, ER1
Huskamp, HA1
Alexander, GC1
Newcorn, JH1
Ickowicz, A1
Spencer, TJ6
Biederman, J10
Wilens, TE9
Kowatch, RA1
Sethuraman, G1
Hume, JH1
Kromelis, M1
Weinberg, WA1
Prince, JB2
Spencer, T3
Van Patten, SL2
Doyle, R2
Girard, K2
Hammerness, P1
Goldman, S1
Brown, S1
Maidment, ID1
Cotlar, MJ1
Upadhyaya, HP1
Brady, KT1
Wang, W1
Wilens, T2
Waibel, KH1
Katial, RK1
Khurshid, KA1
Decker, DH1
Reeves, G1
Schweitzer, J1
Hammerness, PG1
Kwon, A1
Clark, S1
Scott, M1
Podolski, A1
Ditterline, JW1
Morris, MC1
Moore, H1
Daviss, WB3
Perel, JM2
Rudolph, GR2
Axelson, DA2
Gilchrist, R1
Nuss, S1
Birmaher, B2
Brent, DA2
Himpel, S1
Heise, CA1
Rothenberger, A1
Haight, BR1
Horrigan, JP1
Hudziak, JJ1
Rosenthal, NE1
Connor, DF1
Hampton, KD1
Richard, NE1
Modell, JG1
Levin, FR2
Evans, SM2
Brooks, DJ2
Kalbag, AS1
Garawi, F1
Nunes, EV1
Waxmonsky, JG1
Solhkhah, R2
Daly, J1
Arnsten, AF1
Doyle, AE1
Weiss, MD1
Safren, SA1
Culpepper, L2
Pityaratstian, N1
Papakostas, GI1
Petersen, TJ1
Perlis, RH1
Judy, AE1
Burns, AM1
Alpert, JE1
Birnbaum, RJ1
Fava, M1
Melhem, I1
Kunwar, A1
Dewan, M1
Moura, MA1
Monuteaux, MC2
Wilson, AM1
Lee, MS2
Yang, JW1
Ko, YH1
Han, C1
Kim, SH1
Joe, SH1
Jung, IK1
Reichel, CM1
Linkugel, JD1
Bevins, RA1
Peterson, K1
McDonagh, MS1
Fu, R1
Mészáros, A1
Czobor, P1
Bálint, S1
Simon, V1
Bitter, I1
Szobot, CM1
Bukstein, O1
Ferguson, HB2
Simeon, JG2
Pappas, BA1
Vogel, RA1
Wilson, JH1
Mueller, RA1
Breese, GR1
Barrickman, LL1
Perry, PJ2
Allen, AJ1
Kuperman, S2
Arndt, SV1
Herrmann, KJ1
Schumacher, E1
Jacobsen, LK1
Chappell, P1
Woolston, JL1
Steingard, R1
Conners, CK1
Casat, CD3
Gualtieri, CT1
Weller, E1
Reader, M1
Reiss, A1
Weller, RA1
Khayrallah, M1
Ascher, J1
Cantwell, DP1
Schaller, JL1
Behar, D1
Tilton, P1
Findling, RL1
Dogin, JW1
Hornig, M1
Labbate, LA1
Riggs, PD1
Leon, SL1
Mikulich, SK1
Pottle, LC1
Malek-Ahmadi, P1
Callaghan, RS1
Castaneda, R1
Levy, R1
Hardy, M1
Trujillo, M1
Prince, J1
Polisner, D1
Comeau, S1
Parekh, A1
Bentivoglio, P1
Racusin, R1
Brown, KM1
Bostic, JQ1
Wiley, L1
Ayers, S1
Tobias, JD1
Lewis, BR1
Aoun, SL1
Bernstein, GA1
Crow, SJ1
Gaffney, GR1
Lund, BC1
Bever-Stille, KA1
Arndt, S1
Holman, TL1
Moser, DJ1
Paulsen, JS1
McDowell, DM1
Nunes, E1
Sullivan, MA1
Wender, PH1
Reimherr, FW1
Bloomingdale, LM1
Pleasants, DZ2
Schroeder, DH1
Parler, DW1
Van Wyck Fleet, J2

Clinical Trials (5)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Clinical and Neuropsychological Validity of Attention-Deficit Hyperactivity Disorder in Adulthood[NCT00550667]1,120 participants (Actual)Observational2007-10-01Completed
The Effects of Methylphenidate (MPH) and Non-invasive Brain Stimulation (tDCS) on Inhibitory Control Children With Attention-Deficit/Hyperactivity Disorder (ADHD)[NCT04964427]26 participants (Actual)Interventional2021-02-08Completed
The Relative Efficacy of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD) Versus Medication Only and the Combination of the Two: A Pilot Study[NCT02788851]70 participants (Anticipated)Interventional2016-04-30Active, not recruiting
Maintenance Treatment for Prevention of Smoking Relapse[NCT00063323]Phase 3589 participants (Actual)Interventional2000-08-31Completed
Treatment of Adult ADHD in Methadone Patients[NCT00061087]Phase 2/Phase 3115 participants (Actual)Interventional1998-02-28Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

38 reviews available for bupropion and ADDH

ArticleYear
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
    PloS one, 2020, Volume: 15, Issue:10

    Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bayes

2020
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    The Cochrane database of systematic reviews, 2021, 01-18, Volume: 1

    Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Attention Deficit Disorder with Hyperactiv

2021
The Novelty of Bupropion As a Dopaminergic Antidepressant for the Treatment of Adult Attention Deficit Hyperactive Disorder.
    Current drug targets, 2019, Volume: 20, Issue:2

    Topics: Adult; Animals; Attention Deficit Disorder with Hyperactivity; Bupropion; Clinical Trials as Topic;

2019
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.
    The Cochrane database of systematic reviews, 2017, 10-02, Volume: 10

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants;

2017
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
    The lancet. Psychiatry, 2018, Volume: 5, Issue:9

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Attention Deficit Disorder with Hyperactivi

2018
Psychopharmacology and psychotherapy for the treatment of adults with ADHD-a systematic review of available meta-analyses.
    CNS spectrums, 2013, Volume: 18, Issue:6

    Topics: Attention Deficit Disorder with Hyperactivity; Bupropion; Databases, Factual; Humans; Psychotherapy;

2013
Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
    Journal of affective disorders, 2015, Jun-01, Volume: 178

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with

2015
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
    Expert review of neurotherapeutics, 2016, Volume: 16, Issue:2

    Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder wi

2016
A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
    Journal of child and adolescent psychopharmacology, 2017, Volume: 27, Issue:2

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Dopamine Uptake Inhibit

2017
Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review.
    Advances in therapy, 2009, Volume: 26, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents; Antidepressive Agents, Tric

2009
Review of ADHD pharmacotherapies: advantages, disadvantages, and clinical pearls.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2009, Volume: 48, Issue:3

    Topics: Adolescent; Adrenergic alpha-Agonists; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hy

2009
Attention-deficit-hyperactivity disorder: an update.
    Pharmacotherapy, 2009, Volume: 29, Issue:6

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Antidepressive Agents, Second-Generati

2009
A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    The Journal of clinical psychiatry, 2010, Volume: 71, Issue:6

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Age Factors; Atomoxetine Hydrochloride; Attention D

2010
Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.
    CNS drugs, 2011, Sep-01, Volume: 25, Issue:9

    Topics: Adrenergic Uptake Inhibitors; Adult; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder

2011
Bupropion for adults with attention-deficit hyperactivity disorder: meta-analysis of randomized, placebo-controlled trials.
    Psychiatry and clinical neurosciences, 2011, Volume: 65, Issue:7

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Delayed-Action Preparations; Female

2011
[Diagnosis and treatment of attention deficit hyperactivity disorder in adults].
    Revista de neurologia, 2012, Feb-29, Volume: 54 Suppl 1

    Topics: Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autom

2012
Novel treatments for attention-deficit/hyperactivity disorder in children.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 12

    Topics: Adolescent; Age Factors; Amphetamine; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Ato

2002
Non-stimulant treatment of attention-deficit/hyperactivity disorder.
    CNS spectrums, 2003, Volume: 8, Issue:4

    Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Antidepressive Agents, Tricyclic; Atomoxetine Hydr

2003
The use of antidepressants to treat attention deficit hyperactivity disorder in adults.
    Journal of psychopharmacology (Oxford, England), 2003, Volume: 17, Issue:3

    Topics: Adult; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivi

2003
Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.
    The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:1

    Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Antidepressiv

2004
ADHD treatment across the life cycle.
    The Journal of clinical psychiatry, 2004, Volume: 65 Suppl 3

    Topics: Adolescent; Adult; Aging; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic

2004
Impact of ADHD and its treatment on substance abuse in adults.
    The Journal of clinical psychiatry, 2004, Volume: 65 Suppl 3

    Topics: Adult; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disord

2004
Pharmacological management of attention-deficit hyperactivity disorder.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:6

    Topics: Adrenergic alpha-Agonists; Amphetamines; Antidepressive Agents; Atomoxetine Hydrochloride; Attention

2004
The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.
    Expert opinion on drug safety, 2005, Volume: 4, Issue:2

    Topics: Adrenergic alpha-Agonists; Adult; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Atten

2005
Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.
    Essential psychopharmacology, 2005, Volume: 6, Issue:5

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricy

2005
Advances in alternative pharmacotherapy of ADHD.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2005, Volume: 88 Suppl 4

    Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperac

2005
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
    The Journal of clinical psychiatry, 2006, Volume: 67 Suppl 8

    Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Defici

2006
Primary care treatment of attention-deficit/hyperactivity disorder.
    The Journal of clinical psychiatry, 2006, Volume: 67 Suppl 8

    Topics: Adult; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Attitu

2006
Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder.
    Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:5

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Anxiety Disorder

2007
Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.
    Psychopharmacology, 2008, Volume: 197, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Adult; Adverse Drug Reaction Reporting Systems; Atomoxetine Hydrochlor

2008
[Pharmacotherapy of adult Attention Deficit/Hyperactivity Disorder (ADHD): a systematic review].
    Psychiatria Hungarica : A Magyar Pszichiatriai Tarsasag tudomanyos folyoirata, 2007, Volume: 22, Issue:4

    Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochlo

2007
Attention deficit hyperactivity disorder and substance use disorders.
    Child and adolescent psychiatric clinics of North America, 2008, Volume: 17, Issue:2

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimula

2008
ADHD through the life span: the role of bupropion in treatment.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 4

    Topics: Adolescent; Adult; Age Factors; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Cli

1998
Attention-deficit/hyperactivity disorder: a life-span perspective.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 7

    Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hy

1998
Psychopharmacology of ADHD: children and adolescents.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 7

    Topics: Adolescent; Age Factors; Amphetamines; Antidepressive Agents, Tricyclic; Attention Deficit Disorder

1998
Addressing comorbidity in adults with attention-deficit/hyperactivity disorder.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 7

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Attention Deficit

1998
Bupropion overdose in an adolescent.
    Pediatric emergency care, 2001, Volume: 17, Issue:2

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Dopamine Uptake Inhibitors; Dr

2001
Nicotine dependence: the role for antidepressants and anxiolytics.
    Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:2

    Topics: Alcoholism; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Attention Deficit Disorde

2002

Trials

20 trials available for bupropion and ADDH

ArticleYear
Bupropion in adults with Attention-Deficit/Hyperactivity Disorder: a randomized, double-blind study.
    Acta medica Iranica, 2014, Volume: 52, Issue:9

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Double-Blind Method; Female; Humans

2014
Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.
    Human psychopharmacology, 2012, Volume: 27, Issue:4

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Dopamine Uptake Inhibit

2012
Combination pharmacotherapy in children and adolescents with bipolar disorder.
    Biological psychiatry, 2003, Jun-01, Volume: 53, Issue:11

    Topics: Adolescent; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Attention Deficit Disorde

2003
An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder.
    Biological psychiatry, 2003, Jul-01, Volume: 54, Issue:1

    Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivi

2003
Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.
    The Journal of clinical psychiatry, 2005, Volume: 66, Issue:2

    Topics: Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Blood Pre

2005
Steady-state pharmacokinetics of bupropion SR in juvenile patients.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:4

    Topics: Adolescent; Age Factors; Antidepressive Agents, Second-Generation; Area Under Curve; Attention Defic

2005
Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study.
    Biological psychiatry, 2005, Apr-01, Volume: 57, Issue:7

    Topics: Analysis of Variance; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hype

2005
Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
    Drug and alcohol dependence, 2006, Feb-01, Volume: 81, Issue:2

    Topics: Adult; Algorithms; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Attention Deficit D

2006
A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder.
    The Journal of clinical psychiatry, 2007, Volume: 68, Issue:7

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Dopamine Uptake Inhibit

2007
Evaluating drug effects on children's cognitive functioning.
    Progress in neuro-psychopharmacology & biological psychiatry, 1984, Volume: 8, Issue:4-6

    Topics: Alprazolam; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Bupropion; Child; Child

1984
Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1995, Volume: 34, Issue:5

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Cross-Over Studies; Dos

1995
Bupropion hydrochloride in attention deficit disorder with hyperactivity.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1996, Volume: 35, Issue:10

    Topics: Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bupropion;

1996
An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1998, Volume: 37, Issue:12

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Conduct Disorder; Dopamine Upt

1998
A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults.
    The American journal of psychiatry, 2001, Volume: 158, Issue:2

    Topics: Adult; Age Factors; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hypera

2001
Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2001, Volume: 40, Issue:3

    Topics: Administration, Oral; Adolescent; Antidepressive Agents, Second-Generation; Attention Deficit Disord

2001
Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2001, Volume: 13, Issue:3

    Topics: Adrenergic Agents; Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Dopamine Uptake

2001
Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder.
    Journal of addictive diseases, 2002, Volume: 21, Issue:2

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Cocaine-Related Disorders; Comorbid

2002
Bupropion treatment of attention-deficit hyperactivity disorder in adults.
    The American journal of psychiatry, 1990, Volume: 147, Issue:8

    Topics: Adult; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Bupropion; Clinical Tri

1990
Bupropion in children with attention deficit disorder.
    Psychopharmacology bulletin, 1989, Volume: 25, Issue:2

    Topics: Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Double-Blind Method; Humans; Propio

1989
A double-blind trial of bupropion in children with attention deficit disorder.
    Psychopharmacology bulletin, 1987, Volume: 23, Issue:1

    Topics: Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Double-Blind Method; Female; Humans

1987

Other Studies

37 other studies available for bupropion and ADDH

ArticleYear
Adult attention deficit/hyperactivity disorder in the ambulatory care setting: Erratum.
    JAAPA : official journal of the American Academy of Physician Assistants, 2020, Volume: 33, Issue:11

    Topics: Ambulatory Care; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion

2020
Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
    JAMA pediatrics, 2021, 09-01, Volume: 175, Issue:9

    Topics: Adolescent; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity;

2021
Incidence and risk of attention-deficit hyperactivity disorder in children with amblyopia: A nationwide cohort study.
    Clinical & experimental ophthalmology, 2019, Volume: 47, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Amblyopia; Atomoxetine Hydrochloride; Attention Deficit Disorder with

2019
ADHD and pregnancy.
    The American journal of psychiatry, 2014, Volume: 171, Issue:7

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants;

2014
Differential effects of bupropion on acquisition and performance of an active avoidance task in male mice.
    Behavioural processes, 2016, Volume: 124

    Topics: Animals; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Bupropion; Conditioning,

2016
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
    BMJ open, 2017, 01-10, Volume: 7, Issue:1

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Attention Deficit Disorder with Hyperactivi

2017
The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database.
    Current drug safety, 2008, Volume: 3, Issue:2

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with

2008
Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2008, Volume: 10, Issue:12

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Comorbidity; Compulsive Behavior; D

2008
Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2010, Volume: 55, Issue:3

    Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders;

2010
Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring.
    Journal of developmental and behavioral pediatrics : JDBP, 2010, Volume: 31, Issue:8

    Topics: Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bipo

2010
Resolution of severe obsessive--compulsive disorder after a small unilateral nondominant frontoparietal infarct.
    The International journal of neuroscience, 2011, Volume: 121, Issue:7

    Topics: Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Brai

2011
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.
    Psychiatric services (Washington, D.C.), 2013, Apr-01, Volume: 64, Issue:4

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Amphetamines; Atomox

2013
Bupropion for adults with attention deficit hyperactivity disorder.
    Current psychiatry reports, 2002, Volume: 4, Issue:2

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Clinical Trials as Topic; Dopamine

2002
Bupropion-methylphenidate combination and grand mal seizures.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2002, Volume: 47, Issue:8

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Depressive Disorder; Dose-Resp

2002
Attention deficit hyperactivity disorder (ADHD)--life insurance implications.
    Journal of insurance medicine (New York, N.Y.), 2003, Volume: 35, Issue:1

    Topics: Actuarial Analysis; Adolescent; Adult; Antidepressive Agents, Second-Generation; Attention Deficit D

2003
Bupropion SR in adolescents with comorbid ADHD and nicotine dependence: a pilot study.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2004, Volume: 43, Issue:2

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Dopamine Uptake Inhibit

2004
Serum sickness-like reaction and bupropion.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2004, Volume: 43, Issue:5

    Topics: Adolescent; Anti-Inflammatory Agents; Attention Deficit Disorder with Hyperactivity; Bupropion; Dopa

2004
Bupropion insufflation in a teenager.
    Journal of child and adolescent psychopharmacology, 2004,Spring, Volume: 14, Issue:1

    Topics: Administration, Inhalation; Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Fe

2004
Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders.
    Journal of child and adolescent psychopharmacology, 2005, Volume: 15, Issue:5

    Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Delayed-Action P

2005
New developments in the treatment of ADHD.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:1

    Topics: Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperac

2006
A survey of antidepressant prescribing practices in major depression with comorbid attention-deficit hyperactivity disorder.
    Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:2

    Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Bupropion; C

2006
Steady-state clinical pharmacokinetics of bupropion extended-release in youths.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:12

    Topics: Adolescent; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity;

2006
Treatment of comorbid attention deficit hyperactivity disorder and depression in pediatric patient.
    Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2007, Volume: 29, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bupropion;

2007
Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder.
    Child psychiatry and human development, 2008, Volume: 39, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Biomarkers;

2008
Nicotine as a conditioned stimulus: impact of attention-deficit/hyperactivity disorder medications.
    Experimental and clinical psychopharmacology, 2007, Volume: 15, Issue:5

    Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal;

2007
Drug alterations of punished responding after chlordiazepoxide: possible screen for agents useful in minimal brain dysfunction.
    Pharmacology, biochemistry, and behavior, 1981, Volume: 15, Issue:5

    Topics: Animals; Attention Deficit Disorder with Hyperactivity; Bupropion; Chlordiazepoxide; Conditioning, O

1981
Bupropion and compulsive behavior.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1994, Volume: 33, Issue:1

    Topics: Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Compulsive Behavior; Dextroamphetam

1994
Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1993, Volume: 32, Issue:1

    Topics: Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clonidine; Desipramine; Female; Hum

1993
Treatment of a case of comorbid bipolar disorder and attention-deficit/hyperactivity disorder.
    The Journal of neuropsychiatry and clinical neurosciences, 1998,Spring, Volume: 10, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Antimanic Agents; Attention Deficit Disorder with H

1998
Bupropion and guanfacine.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1998, Volume: 37, Issue:7

    Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with

1998
Bupropion-SR-induced increased libido and spontaneous orgasm.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1998, Volume: 43, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bupr

1998
Bupropion, periodic limb movement disorder, and ADHD.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1999, Volume: 38, Issue:6

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Dopamine Uptake Inhibitors; Fe

1999
Appetite and weight in children treated for ADHD.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1999, Volume: 38, Issue:7

    Topics: Appetite Regulation; Attention Deficit Disorder with Hyperactivity; Body Weight; Bupropion; Central

1999
Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults.
    Psychiatric services (Washington, D.C.), 2000, Volume: 51, Issue:2

    Topics: Adult; Algorithms; Amphetamines; Antidepressive Agents, Second-Generation; Attention Deficit Disorde

2000
Pharmacokinetic interactions between cyclosporine and bupropion or methylphenidate.
    Journal of child and adolescent psychopharmacology, 2001,Summer, Volume: 11, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bupropion;

2001
Change from Mg-pemoline to bupropion in a 12-year-old boy with attention-deficit hyperactivity disorder.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:5

    Topics: Antidepressive Agents; Attention; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; D

1990
Bupropion effects in attention deficit and conduct disorders.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1986, Volume: 31, Issue:6

    Topics: Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Bupropion; Child;

1986